Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

Systemic therapy options in BRCA mutation-associated breast cancer

(2012) Soley Bayraktar et al.   BREAST CANCER RESEARCH AND TREATMENT

Response to DNA damage of CHEK2 missense mutations in familial breast cancer

(2012) Wendy Roeb et al.   HUMAN MOLECULAR GENETICS

CHEK2*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast Cancer

(2012) Maren Weischer et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes

(2011) Jord H. A. Nagel et al.   BREAST CANCER RESEARCH AND TREATMENT

Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes

(2011) Muhammad Riaz et al.   BREAST CANCER RESEARCH AND TREATMENT

Management of Women With BRCA Mutations

(2011) Nadine Tung   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer

(2011) Cezary Cybulski et al.   JOURNAL OF CLINICAL ONCOLOGY

Chek2 DNA Damage Response Pathway and Inherited Breast Cancer Risk

(2011) Nadine Tung et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

(2010) Kerryn W. Reding et al.   BREAST CANCER RESEARCH AND TREATMENT

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age

(2010) Dorina M. van der Kolk et al.   BREAST CANCER RESEARCH AND TREATMENT

Discovering moderate-risk breast cancer susceptibility genes

(2010) Antoinette Hollestelle et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer inBRCA1andBRCA2Mutation Carriers

(2009) Mieke Kriege et al.   JOURNAL OF CLINICAL ONCOLOGY

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2009) Monika K. Graeser et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study

(2008) L Mellemkjær et al.   BRITISH JOURNAL OF CANCER

CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls

(2008) Maren Weischer et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Systemic Adjuvant Treatment on Risk for Contralateral Breast Cancer in the Women's Environment, Cancer and Radiation Epidemiology Study

(2007) Lisbeth Bertelsen et al.   JNCI-Journal of the National Cancer Institute